B2DB — Who said what, where, and when

Mark Piskadlo

Vice President, Cell Therapy Manufacturing, Bristol Myers Squibb

Mark Piskadlo is the Vice President of Operations and Site Lead for the Summit, NJ campus at BMS. Since 2022, he is responsible for the Commercial production of Abecma and Breyanzi, two innovative autologous CAR-T treatments for different forms of blood cancer.

Events Mark Piskadlo has spoken at